Pharmexa has been informed that the announcement of the Extraordinary General Meeting on April 22, 2009 was not sent in a timely manner to everyone of the registered shareholders. One of the proposals on the agenda for the Extraordinary General Meeting requires a 9/10 majority and, as a consequence of this, the announcement must be sent to all registered shareholders at least 8 days in advance in order to comply with the notification requirements according to the Danish Corporate Law. By error, Pharmexa's service provider sent out the announcement one day too late to the shareholders. This means that the announcement does not meet the notification requirements according to Danish Corporate Law. It has therefore been decided to cancel the Extraordinary General Meeting on April 22, 2009 and call for a new meeting with the same agenda. The new Extraordinary General Meeting is expected to take place on Tuesday May 5, 2009 at 16:00. Pharmexa does not expect that this regrettable error will cause the company any extra costs. For the sake of good order it should be noted that for the now cancelled Extraordinary General Meeting Pharmexa has received power of attorney from 8.92% of the company shareholders including H. Lundbeck A/S. Hørsholm, April 20, 2009 Ole Steen Andersen Chairman of the board of directors, Pharmexa A/S Additional information: Claude Mikkelsen, Senior Vice President, Finance & Investor Relations, tel +45 4516 2525 or +45 4060 2558 Achim Kaufhold, Chief Executive Officer, tel +45 4516 2525
Pharmexa to cancel the Extraordinary General Meeting scheduled for April 22, 2009 and to convene an Extraordinary General Meeting expected to take place on May 5, 2009
| Source: Affitech A/S